Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

NxStage Medical gets CE mark for NxGen hemodialysis system

Medical technology company NxStage Medical has secured CE mark approval for its next generation hemodialysis system.

This innovative system consists of new features and capabilities, including a new touchscreen user interface and integrated blood pressure monitor designed to enhance ease of use for patients performing home hemodialysis.

"Our next generation system was developed with extensive patient and customer feedback and builds on our decade long experience in providing life-changing therapy with the NxStage® System One™ to over 30 thousand patients in their homes around the world," said Joseph E. Turk, president of NxStage Medical, Inc.

 "We are very excited to expand our portfolio and begin providing patients with new features and capabilities that are designed to significantly improve their therapy experience."

NxStage's next generation hemodialysis system is currently under review for 510(k) clearance from the United States Food and Drug Administration.

The NxStage System One is the first and only truly portable hemodialysis system cleared specifically by the FDA for home hemodialysis and home nocturnal hemodialysis. Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy.

When combined with the NxStage PureFlow™ SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on-site on-demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate.

Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, including while they are sleeping – at home or on vacation and at a medically appropriate treatment frequency.

 In addition, NxStage's Nx2me Connected Health® platform collects important NxStage System One and patient information for flexible viewing, monitoring and reporting that may improve patient management and patient retention, as well as simplify alternative site care.

The System One is also used to provide a range of flexible therapy options in more traditional care settings such as hospitals and dialysis centers.